Caris Life Sciences, Inc.

Caris Life Sciences, Inc. is a healthcare technology company specializing in precision medicine and advanced diagnostics. As a next-generation AI TechBio firm, Caris is renowned for its comprehensive molecular profiling services, utilizing whole exome and whole transcriptome sequencing coupled with artificial intelligence and machine learning. This enables the company to offer in-depth clinico-genomic insights that support early detection, diagnosis, monitoring, therapy selection, and drug development in complex diseases, particularly cancer. Caris's suite of solutions includes multi-cancer companion diagnostics and tumor profiling tests, which aim to match patients with targeted therapies based on their unique molecular makeup. With its headquarters in Irving, Texas, and a presence in major global life sciences hubs, Caris Life Sciences plays a pivotal role in advancing precision healthcare and supporting clinicians, patients, and biopharma partners with robust, scalable data-driven platforms designed to unravel disease complexity and enhance treatment outcomes.